-
1Academic Journal
المؤلفون: Feld, Jordan, J, Forns, Xavier, Dylla, Douglas, E, Kumada, Hiromitsu, de Ledinghen, Victor, Wei, Lai, Brown, Robert, S, Flisiak, Robert, Lampertico, Pietro, Thabut, Dominique, Bondin, Mark, Tatsch, Fernando, Burroughs, Margaret, Marcinak, John, Zhang, Zhenzhen, Emmett, Amanda, Jacobson, Ira, M
المساهمون: CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
المصدر: ISSN: 1352-0504.
مصطلحات موضوعية: AE, Adverse event ALT, Alanine aminotransferase AST, Aspartate aminotransferase CC, Compensated cirrhosis CI, Confidence interval CKD, Chronic kidney disease DAA, Direct-acting antiviral eGFR, estimated glomerular filtration rate G/P, Glecaprevir/pibrentasvir GT, Genotype HCC, Hepatocellular carcinoma HCV, Hepatitis C virus HIV, Human immunodeficiency virus IFN, Interferon MedDRA, Medical Dictionary for Regulatory Activities MELD, Model for End-Stage Liver Disease PI, Protease inhibitor PMOS, Post-marketing observational studies SVR, sustained virologic response SVR12, Sustained virologic response at post-treatment Week 12 ULN, upper limit of normal, Adverse event, ALT, Alanine aminotransferase, AST, Aspartate aminotransferase, CC, Compensated cirrhosis, CI
Relation: info:eu-repo/semantics/altIdentifier/pmid/36036117; hal-04409816; https://hal.science/hal-04409816; https://hal.science/hal-04409816/document; https://hal.science/hal-04409816/file/Journal%20of%20Viral%20Hepatitis%20-%202022%20-%20Feld%20-%20Safety%20analysis%20of%20glecaprevir%20pibrentasvir%20in%20patients%20with%20markers%20of%20advanced.pdf; PUBMED: 36036117; PUBMEDCENTRAL: PMC9827821
الاتاحة: https://hal.science/hal-04409816
https://hal.science/hal-04409816/document
https://hal.science/hal-04409816/file/Journal%20of%20Viral%20Hepatitis%20-%202022%20-%20Feld%20-%20Safety%20analysis%20of%20glecaprevir%20pibrentasvir%20in%20patients%20with%20markers%20of%20advanced.pdf
https://doi.org/10.1111/jvh.13738 -
2Academic Journal
المؤلفون: Feld, Jordan, J, Forns, Xavier, Dylla, Douglas, E, Kumada, Hiromitsu, de Ledinghen, Victor, Wei, Lai, Brown, Robert, S, Flisiak, Robert, Lampertico, Pietro, Thabut, Dominique, Bondin, Mark, Tatsch, Fernando, Burroughs, Margaret, Marcinak, John, Zhang, Zhenzhen, Emmett, Amanda, Jacobson, Ira, M
المساهمون: CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
المصدر: ISSN: 1352-0504.
مصطلحات موضوعية: AE, Adverse event ALT, Alanine aminotransferase AST, Aspartate aminotransferase CC, Compensated cirrhosis CI, Confidence interval CKD, Chronic kidney disease DAA, Direct-acting antiviral eGFR, estimated glomerular filtration rate G/P, Glecaprevir/pibrentasvir GT, Genotype HCC, Hepatocellular carcinoma HCV, Hepatitis C virus HIV, Human immunodeficiency virus IFN, Interferon MedDRA, Medical Dictionary for Regulatory Activities MELD, Model for End-Stage Liver Disease PI, Protease inhibitor PMOS, Post-marketing observational studies SVR, sustained virologic response SVR12, Sustained virologic response at post-treatment Week 12 ULN, upper limit of normal, Adverse event, ALT, Alanine aminotransferase, AST, Aspartate aminotransferase, CC, Compensated cirrhosis, CI
Relation: info:eu-repo/semantics/altIdentifier/pmid/36036117; hal-04409816; https://hal.science/hal-04409816; https://hal.science/hal-04409816/document; https://hal.science/hal-04409816/file/Journal%20of%20Viral%20Hepatitis%20-%202022%20-%20Feld%20-%20Safety%20analysis%20of%20glecaprevir%20pibrentasvir%20in%20patients%20with%20markers%20of%20advanced.pdf; PUBMED: 36036117; PUBMEDCENTRAL: PMC9827821
الاتاحة: https://hal.science/hal-04409816
https://hal.science/hal-04409816/document
https://hal.science/hal-04409816/file/Journal%20of%20Viral%20Hepatitis%20-%202022%20-%20Feld%20-%20Safety%20analysis%20of%20glecaprevir%20pibrentasvir%20in%20patients%20with%20markers%20of%20advanced.pdf
https://doi.org/10.1111/jvh.13738